Research from Saint Louis University finds that among patients at risk for opioid misuse, the odds of receiving a Schedule II opioid (those with high abuse potential) for non-cancer pain were similar to those not at risk, despite new prescribing guidelines from the Centers for Disease Control (CDC).
- How heavy is dark matter? Scientists radically narrow the potential mass range for the first time
- Engineers share model for ventilating two patients with one ventilator
- Social media study reveals diabetics’ fear of disrupted insulin supplies because of Brexit
- COVID-19 increases mortality rate among pregnant women
- How climate caprices can trigger plants